Health system pharmacies now face implementing new USP 795 & 797 standards while meeting a growing demand for compounded medications. Partnering with PCCA gives your pharmacy access to the formulations, stability data, staff training and experienced support to navigate this growth of compounding operations. Let PCCA help you improve quality and patient safety, reduce costs and achieve regulatory compliance.
New!
75+ Researched Sterile Formulations
To help support ASHP’s Standardize 4 Safety initiative, PCCA offers this list of Sterile formulas for the Pediatric and Adult Continuous Infusion standardized concentrations.
Explore Virtual USP Training for Health Systems:
Free Webinars:
Instantly access thousands of validated master formula records and hundreds of formulas backed by stability-indicating assays, supporting extended beyond-use data.
Ensure your staff is trained to confidently compound sterile and nonsterile preparations including hazardous drugs while complying with the latest regulatory guidance and achieving best practices.
9,000+ Validated Master Formulation Records, including Standardized 4 Safety and MI Peds formulations
Formula Stability Data – 200+ formulas with extended beyond-use dates backed by stability indicating studies and USP Chapter 51 antimicrobial effectiveness testing
Formulas updated to comply with USP Chapters 795 and 797 revisions (November 1, 2023)
Clinical support to scale formulas when creating larger or smaller volumes of formulations than the original master formulation record.
PCCA’s easy-to-implement, ACPE accredited eLearning program offers your health system the curriculum, tools and resources needed to meet the most current USP 795 training compliance standards.
Need help with USP implementation, formulation guidance or unique clinical questions? PCCA’s team of more than 20 pharmacists expertly guide health system pharmacy teams.
Make sure your compounding facility meets necessary standards with a thorough gap analysis.
Extemporaneous formulation guidance (appropriate pH, compatibility, solubility, tonicity, osmolarity, calculations, using certificates of analysis)
Researching therapeutic options for unique patient needs
Implementation of USP standards and FDA Insanitary Conditions Guidance
Review compliance with Joint Commission, USP 795/797/800, 503A and FDA Insanitary Conditions Guidance
Evaluate compounding facilities, workflow and operations
Assess staff and compounding area preparation, SOPs and documentation
Live virtual USP training designed for health system pharmacies. No travel required — just compliance-ready education that works with your timeline.
July 21–22 — Nonsterile Compounding (USP 795/800) Get Info & Register ►
September 23–25 — Sterile Compounding (USP 797/800) Get Info & Register ►
More than 40 years ago, PCCA began helping pharmacists create compounded medications for hospital patients when traditional medications were discontinued or unavailable for patients. Today, we guide health system pharmacies in all aspects of compounding to ensure regulatory compliance and deliver high-quality compounded medications to patients.
Terms of Use
Privacy Statement
Cookie Consent Notice
Website Accessibility
Do Not Sell or Share My Personal Information
We're working to improve website accessibility. Need help? Call 800.331.2498 or view our Accessibility Notice.